Featured Articles
-
Life Sciences Companies Talk Past, Present, And Future at JPM
3/21/2025
The 43rd annual J.P. Morgan Healthcare Conference featured presentations from a host of large, medium, and small-cap life sciences companies that discussed past performance and future outlooks.
-
Continued Growth In Pharma R&D For 2024
3/21/2025
Explore this breakdown of the key findings in Citeline's full Pharma R&D Annual Review 2025 through easy-to-understand graphs and charts that highlight trends in the R&D pipeline.
-
Rare Disease R&D: Continued Growth Amid Challenges
3/21/2025
The market for rare disease treatments continues to grow but it is not without its challenges, including small patient populations and a lack of existing research.
-
Outlook 2025: Key Trends & Insights
2/19/2025
Dive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies.
-
Answer Your Critical Clinical Questions — Faster Than Ever
2/19/2025
Pressing clinical planning questions to ask about feasibility, investigator selection, patient enrollment, clinical trial disclosure, and more.
-
Antibody-Drug Conjugates: 'Magic Bullets' Become Reality
2/19/2025
Cancer therapy has evolved from potent chemotherapy to targeted biological therapy, including antibody-drug conjugates (ADCs). Learn more about ADCs’ makeup, mechanisms, and the development landscape.
-
The Scoop On The SCOPE Summit
2/19/2025
From industry partnerships to patient recruitment to proprietary data, SCOPE 2025 was packed with informational sessions.
-
Merits Of A Multifaceted Approach To Clinical Trial Recruitment
1/27/2025
The best way to address clinical trial recruitment challenges is with a multifaceted approach that goes beyond traditional channels and ways of thinking.
-
Use Case: A Patient-Centric Approach To Site Selection
1/27/2025
Discover how Citeline’s robust datasets, combined with real-world data, inform intelligent site and investigator selection for a rare, autoimmune disease.
-
What's The Current & Future Impact Of AI On Pharmaceutical R&D
1/17/2025
Explore the results of a survey where senior decision-makers in the life sciences industry provided their perceptions and expectations of AI to understand current AI adoption trends.